ConductScience.org, home

Paper6252915

Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.

Sanders GL and 2 others. Br J Clin Pharmacol, 1980. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment. Papers, record 6252915. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6252915

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1980
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-05-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sanders GLG L
2Davies DMD M
3Rawlins MDM D

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PressureMajor topic
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Receptors, AdrenergicMajor topic
Receptors, Adrenergic, betaMajor topic
Administration, Oral
Adult
Humans
Kinetics
Male
Middle Aged
Time Factors

Source PubMed

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,884,654Blood levels of drug at the equilibrium state after multiple dosing.Nature1965https://conductscience.org/library/papers/5884654PubMed
25,410,893Plasma propranolol levels in adults with observations in four children.Clin Pharmacol Ther1970https://conductscience.org/library/papers/5410893PubMed
34,189,587A random-zero sphygmomanometer.Lancet1970https://conductscience.org/library/papers/4189587PubMed
45,054,588Relation of propranolol plasma level to beta-blockade during oral therapy.Pharmacology1972https://conductscience.org/library/papers/5054588PubMed
55,055,692Intravenously administered isoproterenol sulfate dose-response curves in man.Arch Intern Med1972https://conductscience.org/library/papers/5055692PubMed
64,419,005Steady-state plasma concentrations of alprenolol in man.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4419005PubMed
79,292Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.Eur J Clin Pharmacol1976https://conductscience.org/library/papers/9292PubMed
81,001,750The metabolism of labetalol in animals and man.Biochem Soc Trans1976https://conductscience.org/library/papers/1001750PubMed
914,010Relationship between plasma concentrations and pharmacological effects of labetalol.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/14010PubMed
10923,180Propranolol serum levels during twenty-four hours.Clin Pharmacol Ther1977https://conductscience.org/library/papers/923180PubMed
11802,650Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.Clin Sci Mol Med Suppl1975https://conductscience.org/library/papers/802650PubMed
12365,543Labetalol, a cross-over double blind controlled trial.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/365543PubMed
13760,749Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/760749PubMed
1413,651,579Some quantitative uses of drug antagonists.Br J Pharmacol Chemother1959https://conductscience.org/library/papers/13651579PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6252915

GET https://conductscience.org/api/papers/v1/6252915/authors